GWPH News and Press, GW Pharmaceuticals Plc From 10/10/19

Stock investors are a picky and often hard-to-please group. With their money they can punish a company for mistakes and transgressions or for not performing as well as they think it should. But in their zeal to sock it to companies that have done wrong, investors frequently oversell a stock. Th...

October 10, 2019 Palm Beach, FL – October 10, 2019 –  As the cannabis market booms, another drug may soon follow in its footsteps — psilocybin mushrooms.  Already, we’re seeing a groundswell of interest.  In fact, activists in California ...

CARLSBAD, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platfo...

For many years, marijuana stocks were the hottest thing on Wall Street . Early investors in brand-name pot stocks managed to generate gains of 1,000%, 3,000%, and even more than 7,000% in some instances in just a few years. But as is true of all next-big-thing industries over the past quarter o...

The Stock Sells At A Fair Price GW Pharmaceuticals ( GWPH ) is oversold, presenting retail investors with an opportunity to buy shares at a fair price. The price per share currently hovers at ~$110.00. Shares sold during the past 52 weeks were hitting a high $196. I once recommended bu...

“What the heck happened to my cannabis stocks?” is the first question on the minds of most investors, with multiple question marks. The second question is, “When will it stop?” The decline since March has been relentless. If misery loves company, it's a crowded room...

Investors looking to capitalize on the growing popularity of medical marijuana may want to consider buying shares of GW Pharmaceuticals (NASDAQ: GWPH) . While the company may not want to refer to itself as a cannabis stock , it's definitely benefiting from the soaring sales growth of its dru...

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Jonathan Liss Today's guest will be familiar to many investors both within and outside of the cannabis space. Tim Seymour of CNBC...

Over the next three weeks, Canada’s Cannabis 2.0 is expected to create even more opportunity for CBD companies. In fact, on October 17, 2019, the country will legalize edibles, beverages, and topicals just a year after approving dried cannabis flower, oils, and sprays. Analysts at Delo...

Will this week go down in cannabis history? It's very possible, thanks to the passing of the SAFE Banking Act in the House of Representatives. This is a potential game-changer for the cannabis retail segment, if it passes in the Senate. Meanwhile, there were also developments with marijuana st...